Whipple disease is a chronic, multisystem infection caused by the actinomycete Tropheryma whipplei. It most commonly presents with weight loss, diarrhea, malabsorption, and migratory arthralgias, and can involve cardiac, neurologic, and ocular systems.
Conditions with similar clinical presentations that must be differentiated from Whipple Disease:
WD is a rare systemic infectious disorder caused by TW with protean gastrointestinal, rheumatologic, neurologic, and other systemic manifestations. (ahmad2022whipple’sdiseasereview pages 1-2, melas2021whipplesdiseasethe pages 1-2)
Note: The retrieved ICD-11/Orphanet mapping papers were methodological and did not provide the WD-specific mappings in the accessible text chunks returned here. (ahmad2022whipple’sdiseasereview pages 1-2)
Host susceptibility / immune context - WD occurs in a small fraction of exposed/carrier individuals, supporting a major role for host susceptibility. In a US inpatient study, TW carriage in stool is reported at ~1–11% in healthy individuals while progression to WD is <0.01%. (ahmad2022whipple’sdiseasereview pages 1-2) - Immunosuppression can worsen or unmask disease, including poor response/worsening under TNF inhibitors in a multicenter cohort. (tison2021rheumatologicalfeaturesof pages 1-2, dolmans2017clinicalmanifestationstreatment pages 18-20)
Occupational/environmental exposure - In a multicenter cohort/review, TW detection in stool was higher in sewage plant workers (12–26%) vs healthy controls, supporting exposure/carriage risk in certain occupations. (tison2021rheumatologicalfeaturesof pages 1-2)
Genetic susceptibility (risk alleles/polymorphisms) - HLA associations have been reported, including HLA-DRB1*13 and HLA-DQB1*06, and cytokine-related polymorphisms such as IL16, proposed to impair antigen presentation and predispose to chronic relapsing disease. (marth2016tropherymawhippleiinfection pages 2-3, dolmans2017clinicalmanifestationstreatment pages 5-7)
No protective genetic variants or environmental protective factors were identified in the retrieved evidence.
A plausible interaction model is supported: environmental/occupational exposure leading to carriage interacts with host immune-genetic susceptibility (HLA/cytokine regulation) to permit intracellular persistence and dissemination. Direct quantitative GxE effect sizes were not identified in the retrieved evidence. (tison2021rheumatologicalfeaturesof pages 1-2, marth2016tropherymawhippleiinfection pages 2-3)
Gastrointestinal (classic WD) - Typical manifestations include chronic diarrhea, abdominal pain, weight loss, and malabsorption (classic intestinal involvement), with PAS-positive foamy macrophages in small-bowel lamina propria. (melas2021whipplesdiseasethe pages 1-2, song2023currentknowledgeof pages 1-2)
Rheumatologic - Arthritis/arthralgia often precedes GI symptoms; in a diagnostic overview case series, the classic course included a prodromal stage where arthritis is the first and most common manifestation (~75%). (melas2021whipplesdiseasethe pages 1-2)
Neurologic/CNS - Neurologic involvement is common and prognostically important; a 2023 CNS cohort reported neurologic involvement in 63.9% (23/36). (mecklenburg2023thespectrumof pages 1-1) - Frequent neurologic domains included cognitive, motor (pyramidal), and oculomotor dysfunction; specific signs such as oculomasticatory myorhythmia and supranuclear vertical gaze palsy are emphasized as WD-specific clues in CNS disease. (mecklenburg2023thespectrumof pages 1-1, mecklenburg2023thespectrumof pages 1-2)
Other organ involvement - Cardiovascular manifestations include culture-negative endocarditis (discussed as part of systemic spectrum in reviews/cohorts). (tison2021rheumatologicalfeaturesof pages 1-2, dolmans2017clinicalmanifestationstreatment pages 10-12) - Lymphadenopathy, fever, pleural/pericardial involvement, and uveitis are reported extraintestinal manifestations. (tison2021rheumatologicalfeaturesof pages 1-2)
(Ontology IDs are provided conceptually; exact HP identifiers should be confirmed against the HPO browser during KB ingestion.) - Chronic diarrhea; abdominal pain; weight loss; malabsorption; lymphadenopathy. (melas2021whipplesdiseasethe pages 1-2, song2023currentknowledgeof pages 1-2) - Arthralgia/arthritis (migratory/seronegative); fever. (tison2021rheumatologicalfeaturesof pages 1-2, melas2021whipplesdiseasethe pages 1-2) - Cognitive impairment/dementia; supranuclear gaze palsy; myorhythmia; seizures (less common); stroke/ischemic cerebrovascular event. (mecklenburg2023thespectrumof pages 1-1, mecklenburg2023thespectrumof pages 1-2)
QoL instruments (SF-36/EQ-5D/PROMIS) and quantitative QoL estimates were not identified in the retrieved evidence. However, the long diagnostic delay and multisystem disability burden (arthritis, GI symptoms, cognitive impairment, stroke) imply substantial functional impact. (melas2021whipplesdiseasethe pages 1-2, mecklenburg2023thespectrumof pages 1-1)
WD is not a monogenic disorder in the retrieved evidence; instead, susceptibility is associated with immune-related polymorphisms and HLA alleles. (marth2016tropherymawhippleiinfection pages 2-3, dolmans2017clinicalmanifestationstreatment pages 5-7)
Variant-level details (HGVS nomenclature), population allele frequencies (gnomAD), and ClinVar classifications were not available in the retrieved evidence.
Not identified in the retrieved evidence.
TW is an intracellular bacterium that can be difficult to culture and often requires molecular methods for detection; after entry, it survives within macrophages and can disseminate systemically. (dolmans2017clinicalmanifestationstreatment pages 1-3, dolmans2017clinicalmanifestationstreatment pages 7-8)
No transcriptomic/proteomic/metabolomic datasets were captured in the retrieved evidence, though intestinal infiltrating cells were described as showing an alternatively activated macrophage transcriptional pattern in the IRIS review. (song2023currentknowledgeof pages 7-9)
Not Mendelian; evidence supports complex susceptibility (HLA/cytokine polymorphisms) rather than single-gene inheritance. (marth2016tropherymawhippleiinfection pages 2-3)
Direct abstract quote (diagnostic histology): - “typical foamy macrophages with granular diastase-resistant inclusions presenting a strong positive PAS reaction.” (Cureus case report/review; Jan 2023; https://doi.org/10.7759/cureus.34029) (viegas2023whyiswhipples pages 7-7)
A large multicenter cohort reported the following sensitivities (classic WD vs non-classic WD): - Stool PCR: 100% vs 75% - Saliva PCR: 100% vs 75% - Small-bowel biopsy PCR: 89% vs 60% - Blood PCR: 50% vs 23% - Urine PCR: 33% vs 13% (tison2021rheumatologicalfeaturesof pages 3-4, tison2021rheumatologicalfeaturesof pages 1-2)
A case review additionally reported performance estimates and interpretive thresholds, including stool specificity ~97.6% and improved PPV when stool+saliva are both positive or fecal load exceeds >32,200 copies/mL. (viegas2023whyiswhipples pages 7-7)
Important expert analysis (antibiotic resistance/choice): - A major microbiology review notes genomic/in vitro evidence consistent with TMP-SMX failure (intrinsic trimethoprim resistance mechanisms) and reports a series in which “all 14 patients who were first treated with co-trimoxazole failed treatment,” supporting doxycycline+hydroxychloroquine as an alternative bactericidal regimen. (dolmans2017clinicalmanifestationstreatment pages 18-20)
No WD-specific interventional clinical trials were retrieved in this run.
No natural disease in non-human species, zoonotic transmission, or animal reservoirs were identified in the retrieved evidence.
No in vivo animal models were identified in the retrieved evidence. Mechanistic work emphasized human mucosal immunology and macrophage biology and historical advances in TW culture, implying in vitro macrophage infection systems as a key experimental platform. (dolmans2017clinicalmanifestationstreatment pages 1-3, dolmans2017clinicalmanifestationstreatment pages 7-8)
Key 2023–2024 sources highlighted above: - Song X et al. Front Immunol. Oct 2023. “Current knowledge of the immune reconstitution inflammatory syndrome in Whipple disease: a review.” https://doi.org/10.3389/fimmu.2023.1265414 (song2023currentknowledgeof pages 1-2) - Mecklenburg J et al. Eur J Neurol. Aug 2023. “The spectrum of central nervous system involvement in Whipple's disease.” https://doi.org/10.1111/ene.15511 (mecklenburg2023thespectrumof pages 1-1) - Ye H et al. BMC Infect Dis. May 2023. “Whipple’s disease presenting as weight gain and constipation in a Chinese woman.” https://doi.org/10.1186/s12879-023-08276-y (ye2023whipple’sdiseasepresenting pages 2-5)
High-authority background reviews used for mechanisms/diagnostics/treatment: - Dolmans RAV et al. Clin Microbiol Rev. Apr 2017. https://doi.org/10.1128/CMR.00033-16 (dolmans2017clinicalmanifestationstreatment pages 13-17, dolmans2017clinicalmanifestationstreatment pages 18-20, dolmans2017clinicalmanifestationstreatment pages 7-8) - Marth T et al. Lancet Infect Dis. Mar 2016. https://doi.org/10.1016/S1473-3099(15)00537-X (marth2016tropherymawhippleiinfection pages 6-7, marth2016tropherymawhippleiinfection pages 2-3)
Epidemiology: - Ahmad AI et al. Medicine. Dec 2022. https://doi.org/10.1097/MD.0000000000032231 (ahmad2022whipple’sdiseasereview pages 2-2) - Elchert JA et al. Dig Dis Sci. Nov 2019. https://doi.org/10.1007/s10620-018-5393-9 (elchert2019epidemiologyofwhipple’s pages 1-3)
References
(melas2021whipplesdiseasethe pages 1-2): Nikolaos Melas, Rasjan Amin, Paula Gyllemark, Amil Haji Younes, and Sven Almer. Whipple's disease: the great masquerader—a high level of suspicion is the key to diagnosis. BMC Gastroenterology, Mar 2021. URL: https://doi.org/10.1186/s12876-021-01664-1, doi:10.1186/s12876-021-01664-1. This article has 31 citations and is from a peer-reviewed journal.
(song2023currentknowledgeof pages 1-2): Xiangyi Song, Ruifeng Duan, Liwei Duan, and Lijuan Wei. Current knowledge of the immune reconstitution inflammatory syndrome in whipple disease: a review. Frontiers in Immunology, Oct 2023. URL: https://doi.org/10.3389/fimmu.2023.1265414, doi:10.3389/fimmu.2023.1265414. This article has 10 citations and is from a peer-reviewed journal.
(mecklenburg2023thespectrumof pages 1-2): Jasper Mecklenburg, Verena Moos, Annette Moter, Eberhard Siebert, Alexander Heinrich Nave, Thomas Schneider, Klemens Ruprecht, and Philipp Euskirchen. The spectrum of central nervous system involvement in whipple's disease. European Journal of Neurology, 30:3417-3429, Aug 2023. URL: https://doi.org/10.1111/ene.15511, doi:10.1111/ene.15511. This article has 11 citations and is from a domain leading peer-reviewed journal.
(ahmad2022whipple’sdiseasereview pages 1-2): Akram I. Ahmad, Colin Wikholm, Ioannis Pothoulakis, Claire Caplan, Arielle Lee, Faith Buchanan, and Won Kyoo Cho. Whipple’s disease review, prevalence, mortality, and characteristics in the united states: a cross-sectional national inpatient study. Medicine, 101:e32231, Dec 2022. URL: https://doi.org/10.1097/md.0000000000032231, doi:10.1097/md.0000000000032231. This article has 18 citations and is from a peer-reviewed journal.
(ahmad2022whipple’sdiseasereview pages 2-3): Akram I. Ahmad, Colin Wikholm, Ioannis Pothoulakis, Claire Caplan, Arielle Lee, Faith Buchanan, and Won Kyoo Cho. Whipple’s disease review, prevalence, mortality, and characteristics in the united states: a cross-sectional national inpatient study. Medicine, 101:e32231, Dec 2022. URL: https://doi.org/10.1097/md.0000000000032231, doi:10.1097/md.0000000000032231. This article has 18 citations and is from a peer-reviewed journal.
(ahmad2022whipple’sdiseasereview pages 2-2): Akram I. Ahmad, Colin Wikholm, Ioannis Pothoulakis, Claire Caplan, Arielle Lee, Faith Buchanan, and Won Kyoo Cho. Whipple’s disease review, prevalence, mortality, and characteristics in the united states: a cross-sectional national inpatient study. Medicine, 101:e32231, Dec 2022. URL: https://doi.org/10.1097/md.0000000000032231, doi:10.1097/md.0000000000032231. This article has 18 citations and is from a peer-reviewed journal.
(elchert2019epidemiologyofwhipple’s pages 5-6): Jamie Ann Elchert, Emad Mansoor, Mohannad Abou-Saleh, and Gregory S. Cooper. Epidemiology of whipple’s disease in the usa between 2012 and 2017: a population-based national study. Digestive Diseases and Sciences, 64:1305-1311, Nov 2019. URL: https://doi.org/10.1007/s10620-018-5393-9, doi:10.1007/s10620-018-5393-9. This article has 73 citations and is from a peer-reviewed journal.
(elchert2019epidemiologyofwhipple’s pages 1-3): Jamie Ann Elchert, Emad Mansoor, Mohannad Abou-Saleh, and Gregory S. Cooper. Epidemiology of whipple’s disease in the usa between 2012 and 2017: a population-based national study. Digestive Diseases and Sciences, 64:1305-1311, Nov 2019. URL: https://doi.org/10.1007/s10620-018-5393-9, doi:10.1007/s10620-018-5393-9. This article has 73 citations and is from a peer-reviewed journal.
(tison2021rheumatologicalfeaturesof pages 1-2): Alice Tison, Pauline Preuss, Clémentine Leleu, François Robin, Adrien Le Pluart, Justine Vix, Guillaume Le Mélédo, Philippe Goupille, Elisabeth Gervais, Grégoire Cormier, Jean-David Albert, Aleth Perdriger, Béatrice Bouvard, Jean-Marie Berthelot, Nathan Foulquier, and Alain Saraux. Rheumatological features of whipple disease. Scientific Reports, Jun 2021. URL: https://doi.org/10.1038/s41598-021-91671-9, doi:10.1038/s41598-021-91671-9. This article has 39 citations and is from a peer-reviewed journal.
(mecklenburg2023thespectrumof pages 1-1): Jasper Mecklenburg, Verena Moos, Annette Moter, Eberhard Siebert, Alexander Heinrich Nave, Thomas Schneider, Klemens Ruprecht, and Philipp Euskirchen. The spectrum of central nervous system involvement in whipple's disease. European Journal of Neurology, 30:3417-3429, Aug 2023. URL: https://doi.org/10.1111/ene.15511, doi:10.1111/ene.15511. This article has 11 citations and is from a domain leading peer-reviewed journal.
(vargasrodriguez2023whipplesdiseasea pages 3-5): LJ Vargas-Rodríguez and JL Ruiz-Muñoz. Whipple's disease: a systematic review of the literature. Unknown journal, 2023.
(mecklenburg2023thespectrumof pages 4-5): Jasper Mecklenburg, Verena Moos, Annette Moter, Eberhard Siebert, Alexander Heinrich Nave, Thomas Schneider, Klemens Ruprecht, and Philipp Euskirchen. The spectrum of central nervous system involvement in whipple's disease. European Journal of Neurology, 30:3417-3429, Aug 2023. URL: https://doi.org/10.1111/ene.15511, doi:10.1111/ene.15511. This article has 11 citations and is from a domain leading peer-reviewed journal.
(tison2021rheumatologicalfeaturesof pages 3-4): Alice Tison, Pauline Preuss, Clémentine Leleu, François Robin, Adrien Le Pluart, Justine Vix, Guillaume Le Mélédo, Philippe Goupille, Elisabeth Gervais, Grégoire Cormier, Jean-David Albert, Aleth Perdriger, Béatrice Bouvard, Jean-Marie Berthelot, Nathan Foulquier, and Alain Saraux. Rheumatological features of whipple disease. Scientific Reports, Jun 2021. URL: https://doi.org/10.1038/s41598-021-91671-9, doi:10.1038/s41598-021-91671-9. This article has 39 citations and is from a peer-reviewed journal.
(marth2016tropherymawhippleiinfection pages 6-7): Thomas Marth, Verena Moos, Christian Müller, Federico Biagi, and Thomas Schneider. Tropheryma whipplei infection and whipple's disease. The Lancet. Infectious diseases, 16 3:e13-22, Mar 2016. URL: https://doi.org/10.1016/s1473-3099(15)00537-x, doi:10.1016/s1473-3099(15)00537-x. This article has 251 citations.
(dolmans2017clinicalmanifestationstreatment pages 18-20): Ruben A. V. Dolmans, C. H. Edwin Boel, Miangela M. Lacle, and Johannes G. Kusters. Clinical manifestations, treatment, and diagnosis of tropheryma whipplei infections. Clinical Microbiology Reviews, 30:529-555, Apr 2017. URL: https://doi.org/10.1128/cmr.00033-16, doi:10.1128/cmr.00033-16. This article has 245 citations and is from a highest quality peer-reviewed journal.
(schiepatti2020longtermmorbidityand pages 6-7): Annalisa Schiepatti, Maria Luisa Nicolardi, Piero Marone, and Federico Biagi. Long-term morbidity and mortality in whipple's disease: a single-center experience over 20 years. Future microbiology, 15:847-854, Jul 2020. URL: https://doi.org/10.2217/fmb-2019-0315, doi:10.2217/fmb-2019-0315. This article has 12 citations and is from a peer-reviewed journal.
(hujoel2019tropherymawhippleiinfection pages 1-2): Isabel A. Hujoel, David H. Johnson, Benjamin Lebwohl, Daniel Leffler, Sonia Kupfer, Tsung-Teh Wu, Joseph A. Murray, and Alberto Rubio-Tapia. Tropheryma whipplei infection (whipple disease) in the usa. Digestive Diseases and Sciences, 64:213-223, Mar 2019. URL: https://doi.org/10.1007/s10620-018-5033-4, doi:10.1007/s10620-018-5033-4. This article has 62 citations and is from a peer-reviewed journal.
(ye2023whipple’sdiseasepresenting pages 2-5): Haiyan Ye, Xiao Hu, Tommy Richard Sun-Wing Tong, Shuang Chen, Tao Li, Fanfan Xing, Jasper Fuk-Woo Chan, Kwok-Yung Yuen, and Kelvin Hei-Yeung Chiu. Whipple’s disease presenting as weight gain and constipation in a chinese woman. BMC Infectious Diseases, May 2023. URL: https://doi.org/10.1186/s12879-023-08276-y, doi:10.1186/s12879-023-08276-y. This article has 2 citations and is from a peer-reviewed journal.
(dolmans2017clinicalmanifestationstreatment pages 1-3): Ruben A. V. Dolmans, C. H. Edwin Boel, Miangela M. Lacle, and Johannes G. Kusters. Clinical manifestations, treatment, and diagnosis of tropheryma whipplei infections. Clinical Microbiology Reviews, 30:529-555, Apr 2017. URL: https://doi.org/10.1128/cmr.00033-16, doi:10.1128/cmr.00033-16. This article has 245 citations and is from a highest quality peer-reviewed journal.
(dolmans2017clinicalmanifestationstreatment pages 7-8): Ruben A. V. Dolmans, C. H. Edwin Boel, Miangela M. Lacle, and Johannes G. Kusters. Clinical manifestations, treatment, and diagnosis of tropheryma whipplei infections. Clinical Microbiology Reviews, 30:529-555, Apr 2017. URL: https://doi.org/10.1128/cmr.00033-16, doi:10.1128/cmr.00033-16. This article has 245 citations and is from a highest quality peer-reviewed journal.
(marth2016tropherymawhippleiinfection pages 2-3): Thomas Marth, Verena Moos, Christian Müller, Federico Biagi, and Thomas Schneider. Tropheryma whipplei infection and whipple's disease. The Lancet. Infectious diseases, 16 3:e13-22, Mar 2016. URL: https://doi.org/10.1016/s1473-3099(15)00537-x, doi:10.1016/s1473-3099(15)00537-x. This article has 251 citations.
(dolmans2017clinicalmanifestationstreatment pages 5-7): Ruben A. V. Dolmans, C. H. Edwin Boel, Miangela M. Lacle, and Johannes G. Kusters. Clinical manifestations, treatment, and diagnosis of tropheryma whipplei infections. Clinical Microbiology Reviews, 30:529-555, Apr 2017. URL: https://doi.org/10.1128/cmr.00033-16, doi:10.1128/cmr.00033-16. This article has 245 citations and is from a highest quality peer-reviewed journal.
(dolmans2017clinicalmanifestationstreatment pages 10-12): Ruben A. V. Dolmans, C. H. Edwin Boel, Miangela M. Lacle, and Johannes G. Kusters. Clinical manifestations, treatment, and diagnosis of tropheryma whipplei infections. Clinical Microbiology Reviews, 30:529-555, Apr 2017. URL: https://doi.org/10.1128/cmr.00033-16, doi:10.1128/cmr.00033-16. This article has 245 citations and is from a highest quality peer-reviewed journal.
(song2023currentknowledgeof pages 7-9): Xiangyi Song, Ruifeng Duan, Liwei Duan, and Lijuan Wei. Current knowledge of the immune reconstitution inflammatory syndrome in whipple disease: a review. Frontiers in Immunology, Oct 2023. URL: https://doi.org/10.3389/fimmu.2023.1265414, doi:10.3389/fimmu.2023.1265414. This article has 10 citations and is from a peer-reviewed journal.
(mecklenburg2023thespectrumof pages 8-9): Jasper Mecklenburg, Verena Moos, Annette Moter, Eberhard Siebert, Alexander Heinrich Nave, Thomas Schneider, Klemens Ruprecht, and Philipp Euskirchen. The spectrum of central nervous system involvement in whipple's disease. European Journal of Neurology, 30:3417-3429, Aug 2023. URL: https://doi.org/10.1111/ene.15511, doi:10.1111/ene.15511. This article has 11 citations and is from a domain leading peer-reviewed journal.
(mecklenburg2023thespectrumof pages 2-3): Jasper Mecklenburg, Verena Moos, Annette Moter, Eberhard Siebert, Alexander Heinrich Nave, Thomas Schneider, Klemens Ruprecht, and Philipp Euskirchen. The spectrum of central nervous system involvement in whipple's disease. European Journal of Neurology, 30:3417-3429, Aug 2023. URL: https://doi.org/10.1111/ene.15511, doi:10.1111/ene.15511. This article has 11 citations and is from a domain leading peer-reviewed journal.
(dolmans2017clinicalmanifestationstreatment pages 13-17): Ruben A. V. Dolmans, C. H. Edwin Boel, Miangela M. Lacle, and Johannes G. Kusters. Clinical manifestations, treatment, and diagnosis of tropheryma whipplei infections. Clinical Microbiology Reviews, 30:529-555, Apr 2017. URL: https://doi.org/10.1128/cmr.00033-16, doi:10.1128/cmr.00033-16. This article has 245 citations and is from a highest quality peer-reviewed journal.
(viegas2023whyiswhipples pages 7-7): Ana Filipa Viegas, Andreia M Lopes, Gabriela Venade, Pedro Rodrigues, and João Tavares. Why is whipple's disease still a challenging diagnosis? a case report and brief review of literature. Cureus, Jan 2023. URL: https://doi.org/10.7759/cureus.34029, doi:10.7759/cureus.34029. This article has 7 citations.
(mecklenburg2023thespectrumof pages 6-7): Jasper Mecklenburg, Verena Moos, Annette Moter, Eberhard Siebert, Alexander Heinrich Nave, Thomas Schneider, Klemens Ruprecht, and Philipp Euskirchen. The spectrum of central nervous system involvement in whipple's disease. European Journal of Neurology, 30:3417-3429, Aug 2023. URL: https://doi.org/10.1111/ene.15511, doi:10.1111/ene.15511. This article has 11 citations and is from a domain leading peer-reviewed journal.
(zhou2024shorttermamoxicillinclavulanate pages 1-2): Hongyuan Zhou and Jian Zhang. Short-term amoxicillin clavulanate in the treatment of pulmonary abscess caused by tropheryma whipplei infection diagnosed by targeted next-generation sequencing: a case report and literature review. Infection and Drug Resistance, 17:4607-4616, Oct 2024. URL: https://doi.org/10.2147/idr.s488740, doi:10.2147/idr.s488740. This article has 6 citations and is from a peer-reviewed journal.
name: Whipple Disease
creation_date: '2026-01-14T23:44:48Z'
updated_date: '2026-04-11T01:06:52Z'
category: Infectious
description: >
Whipple disease is a chronic, multisystem infection caused by the actinomycete
Tropheryma whipplei. It most commonly presents with weight loss, diarrhea,
malabsorption, and migratory arthralgias, and can involve cardiac, neurologic,
and ocular systems.
disease_term:
preferred_term: Whipple disease
term:
id: MONDO:0005116
label: Whipple disease
parents:
- Systemic bacterial infection
- Malabsorption syndrome
infectious_agent:
- name: Tropheryma whipplei
infectious_agent_term:
preferred_term: Tropheryma whipplei
term:
id: NCBITaxon:2039
label: Tropheryma whipplei
description: Gram-positive actinomycete responsible for Whipple disease.
pathophysiology:
- name: Macrophage dysfunction and malabsorption
description: Chronic small bowel infection by Tropheryma whipplei leads to lymphostasis and impaired nutrient absorption driven by macrophage dysfunction.
cell_types:
- preferred_term: macrophage
term:
id: CL:0000235
label: macrophage
biological_processes:
- preferred_term: macrophage activation
term:
id: GO:0042116
label: macrophage activation
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: SUPPORT
snippet: The disease is a chronic infection of the intestinal mucosa with the bacterium Tropheryma whipplei, which leads to a lymphostasis with an impaired absorption of the nutrition.
explanation: Review describes lymphatic obstruction and malabsorption from chronic infection.
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: SUPPORT
snippet: Recent studies suggest that a host-specific dysfunction of the intestinal macrophages is responsible for the chronic infection with T. whipplei.
explanation: Highlights macrophage functional defect underlying persistent infection.
- name: Host susceptibility and immune dysregulation
description: Only a small fraction of exposed individuals develop Whipple disease, implicating rare inborn or acquired immune defects and risk from anti-TNF therapy.
biological_processes:
- preferred_term: immune system process
term:
id: GO:0002376
label: immune system process
evidence:
- reference: PMID:40062480
reference_title: "Human genetics of Whipple's disease."
supports: SUPPORT
snippet: Half the world's population is exposed to T. whipplei, but only one in a million develop WD. This suggests that acquired or inborn errors of immunity (IEI) may underlie WD.
explanation: Genetic review links rare immune defects to disease susceptibility.
- reference: PMID:40062480
reference_title: "Human genetics of Whipple's disease."
supports: SUPPORT
snippet: Anti-TNF treatment is a well established risk factor for flare-ups of WD.
explanation: Notes iatrogenic immune suppression as a trigger for disease activation.
- reference: PMID:32896657
reference_title: "Whipple disease: a 15-year retrospective study on 36 patients with positive polymerase chain reaction for Tropheryma whipplei."
supports: PARTIAL
snippet: About 60% were immunosuppressed. The most frequent clinical presentations were joint pain (16/22), weight loss (15/22) and/or digestive tract disorder (15/22).
explanation: Cohort shows high immunosuppression rate among confirmed Whipple disease cases.
- reference: PMID:37727483
reference_title: "Diagnosis and treatment of Whipple disease after kidney transplantation: A case report."
supports: PARTIAL
snippet: The patient was admitted to the hospital due to recurrent diarrhea for 1 mo, shortness of breath, and 1 wk of fever, after 3 years of renal transplantation.
explanation: Post-transplant case illustrates Whipple disease emerging under chronic immunosuppression.
- name: TNF-inhibitor–driven macrophage apoptosis
description: Anti-TNF biologics can reprogram macrophages infected with Tropheryma whipplei, increasing bacterial replication and macrophage apoptosis, exacerbating latent disease.
cell_types:
- preferred_term: macrophage
term:
id: CL:0000235
label: macrophage
biological_processes:
- preferred_term: apoptotic process
term:
id: GO:0006915
label: apoptotic process
evidence:
- reference: PMID:34093562
reference_title: "Tumor Necrosis Factor Inhibitors Exacerbate Whipple's Disease by Reprogramming Macrophage and Inducing Apoptosis."
supports: SUPPORT
snippet: Etanercept, adalimumab or certolizumab treatment of monocyte-derived macrophages from healthy subjects significantly increased bacterial replication in vitro without affecting uptake.
explanation: Demonstrates TNF inhibitors increase T. whipplei replication within macrophages.
- reference: PMID:34093562
reference_title: "Tumor Necrosis Factor Inhibitors Exacerbate Whipple's Disease by Reprogramming Macrophage and Inducing Apoptosis."
supports: SUPPORT
snippet: TNFI aggravate/exacerbate latent or subclinical undiagnosed Whipple's disease by promoting a strong inflammatory response and apoptosis.
explanation: Study links TNF blockade to apoptosis-driven exacerbation of Whipple disease.
phenotypes:
- name: Chronic diarrhea
category: Gastrointestinal
description: Persistent watery or steatorrheal stools reflecting malabsorption.
phenotype_term:
preferred_term: Diarrhea
term:
id: HP:0002014
label: Diarrhea
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: SUPPORT
snippet: Prior to patients reporting symptoms of a malabsorption syndrome (chronic diarrhea/steatorhea, weight loss), they often suffer from non-specific symptoms.
explanation: Review lists chronic diarrhea as hallmark of Whipple disease malabsorption.
- name: Steatorrhea
category: Gastrointestinal
description: Fatty, malabsorptive stools accompanying chronic infection.
phenotype_term:
preferred_term: Steatorrhea
term:
id: HP:0002570
label: Steatorrhea
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: SUPPORT
snippet: Prior to patients reporting symptoms of a malabsorption syndrome (chronic diarrhea/steatorhea, weight loss), they often suffer from non-specific symptoms.
explanation: Same review notes steatorrhea as part of the malabsorption syndrome.
- name: Weight loss
category: Constitutional
description: Progressive weight loss due to malabsorption.
phenotype_term:
preferred_term: Weight loss
term:
id: HP:0001824
label: Weight loss
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: SUPPORT
snippet: "The weight loss is on average 11 kg (range: 3-36 kg)."
explanation: Quantifies typical weight loss in Whipple disease.
- name: Migratory polyarthralgia
category: Musculoskeletal
description: Migratory peripheral joint pain often preceding gastrointestinal symptoms.
phenotype_term:
preferred_term: Arthralgia
term:
id: HP:0002829
label: Arthralgia
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: SUPPORT
snippet: Patients report a migrating polyarthritis of the peripheral joints (ankles, shoulders, knees, wrists, hands) and of the axial system.
explanation: Describes typical migratory joint involvement.
- reference: PMID:40204565
reference_title: "Isolated joint involvement in Whipple's disease: a cohort study."
supports: SUPPORT
snippet: Joint involvement was similar, with initial episodic migratory arthritis (91 %) predominantly affecting large joints and lasting 2-7 days.
explanation: Cohort of isolated articular Whipple disease shows stereotyped migratory arthritis pattern.
- name: Cognitive dysfunction
category: Neurologic
description: Cognitive impairment and other CNS manifestations that can occur with systemic or isolated CNS disease.
phenotype_term:
preferred_term: Cognitive impairment
term:
id: HP:0100543
label: Cognitive impairment
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: SUPPORT
snippet: Patients complain of headaches, cognitive dysfunctions, and eye motility disorders.
explanation: Review notes cognitive dysfunction among neurological features of Whipple disease.
- name: Fever
category: Constitutional
description: Low-grade to episodic fever during prodromal phase.
phenotype_term:
preferred_term: Fever
term:
id: HP:0001945
label: Fever
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: SUPPORT
snippet: Prior to patients reporting symptoms of a malabsorption syndrome (chronic diarrhea/steatorhea, weight loss), they often suffer from non-specific symptoms (polyarthralgia, fever, fatigue).
explanation: Notes fever among early systemic symptoms.
- name: Abdominal pain
category: Gastrointestinal
description: Colicky abdominal pain accompanying diarrhea and malabsorption.
phenotype_term:
preferred_term: Abdominal pain
term:
id: HP:0002027
label: Abdominal pain
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: SUPPORT
snippet: The clinical symptoms of WD include chronic diarrhea, malnutrition (weight loss), migratory polyarthralgia, abdominal pain, and/or enlarged lymph nodes.
explanation: Review lists abdominal pain among common clinical symptoms.
- name: Lymphadenopathy
category: Hematologic/Immune
description: Enlarged lymph nodes reflecting systemic infection.
phenotype_term:
preferred_term: Lymphadenopathy
term:
id: HP:0002716
label: Lymphadenopathy
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: SUPPORT
snippet: The clinical symptoms of WD include chronic diarrhea, malnutrition (weight loss), migratory polyarthralgia, abdominal pain, and/or enlarged lymph nodes.
explanation: Review notes lymphadenopathy as part of the systemic presentation.
- reference: PMID:40398847
reference_title: "Whipple Disease Initial Presentation as Supraclavicular Lymphadenopathy in a Patient With Rheumatoid Arthritis: A Diagnostic Challenge."
supports: SUPPORT
snippet: A supraclavicular lymph node excisional biopsy revealed complete architectural effacement by a diffuse foamy histiocytic infiltrate without granuloma formation or necrosis.
explanation: Case report shows lymph node involvement with foamy macrophages due to Whipple disease.
- name: Respiratory involvement
category: Respiratory
description: Pulmonary symptoms such as cough, chest pain, and dyspnea with plaques or nodules on imaging.
phenotype_term:
preferred_term: Dyspnea
term:
id: HP:0002094
label: Dyspnea
evidence:
- reference: PMID:38414785
reference_title: "Whipple's disease of the respiratory system: A case report."
supports: SUPPORT
snippet: Whipple's disease (WD) is a multiple-system chronic disease caused by Tropheryma whipplei (T. whipplei) infection. The present study describes 3 cases of WD with clinical manifestations of cough, chest pain, headache, dyspnea, sputum, joint pain, abdominal pain, diarrhea and weight loss.
explanation: Case series documents pulmonary symptoms including dyspnea and chest pain.
- reference: PMID:38414785
reference_title: "Whipple's disease of the respiratory system: A case report."
supports: SUPPORT
snippet: Chest computed tomography (CT) showed signs of plaques, nodules and pleural thickening; and bronchoscopic alveolar lavage fluid metagenomic-sequencing indicated that it was T. whipplei.
explanation: Imaging and BAL sequencing confirm pulmonary involvement due to T. whipplei.
- name: Spinal cord involvement
category: Neurologic
description: Isolated spinal cord inflammation leading to neurologic damage.
phenotype_term:
preferred_term: Abnormality of the nervous system
term:
id: HP:0000707
label: Abnormality of the nervous system
evidence:
- reference: PMID:38525769
reference_title: "Whipple Disease Presenting as Isolated Transverse Myelitis with Permanent Neurological Damage in a Patient with Systemic Lupus Erythematosus: A Case Report of a Difficult Diagnosis with a Literature Review."
supports: SUPPORT
snippet: We describe an atypical case of Whipple disease exclusively involving the spinal cord in an adolescent receiving immunosuppressive therapy for systemic lupus erythematosus.
explanation: Case report highlights spinal cord involvement as a presentation of Whipple disease.
differential_diagnoses:
- name: Crohn disease
distinguishing_features:
- Transmural granulomatous inflammation with skip lesions; lacks PAS-positive macrophages filled with bacteria.
disease_term:
preferred_term: Crohn disease
term:
id: MONDO:0005011
label: Crohn disease
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: PARTIAL
snippet: The clinical symptoms are heterogeneous and challenge differential diagnoses, such as rheumatic diseases, vasculitides, AIDS enteropathy, tuberculosis, or other chronic granulomatous diseases (Crohn's disease, sarcoidosis).
explanation: Review notes Crohn disease as a common granulomatous differential for Whipple disease presentations.
- name: Intestinal tuberculosis
distinguishing_features:
- Caseating granulomas and acid-fast bacilli on Ziehl-Neelsen staining; typically ileocecal involvement.
disease_term:
preferred_term: intestinal tuberculosis
term:
id: MONDO:0001678
label: intestinal tuberculosis
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: PARTIAL
snippet: The clinical symptoms are heterogeneous and challenge differential diagnoses, such as rheumatic diseases, vasculitides, AIDS enteropathy, tuberculosis, or other chronic granulomatous diseases (Crohn's disease, sarcoidosis).
explanation: Article lists tuberculosis among frequent differential diagnoses for Whipple disease.
- name: Sarcoidosis
distinguishing_features:
- Noncaseating granulomas without pathogen; may mimic multisystem involvement but lacks PAS-positive macrophages.
disease_term:
preferred_term: sarcoidosis
term:
id: MONDO:0019338
label: sarcoidosis
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: PARTIAL
snippet: The clinical symptoms are heterogeneous and challenge differential diagnoses, such as rheumatic diseases, vasculitides, AIDS enteropathy, tuberculosis, or other chronic granulomatous diseases (Crohn's disease, sarcoidosis).
explanation: Review highlights sarcoidosis as a granulomatous differential for Whipple disease.
- name: HIV enteropathy
distinguishing_features:
- Occurs with advanced HIV and opportunistic infections; confirmed by HIV testing and low CD4 counts.
disease_term:
preferred_term: HIV infectious disease
term:
id: MONDO:0005109
label: HIV infectious disease
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: PARTIAL
snippet: The clinical symptoms are heterogeneous and challenge differential diagnoses, such as rheumatic diseases, vasculitides, AIDS enteropathy, tuberculosis, or other chronic granulomatous diseases (Crohn's disease, sarcoidosis).
explanation: Paper lists AIDS enteropathy as a key differential diagnosis for Whipple disease.
environmental:
- name: Sewage exposure
description: Higher carriage rates reported in sewage workers, suggesting wastewater as a reservoir.
environment_context:
preferred_term: sewage
term:
id: ENVO:00002018
label: sewage
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: SUPPORT
snippet: High prevalences (approximately 12%) were found in workers who were responsible for the cleaning of sewers.
explanation: Review notes elevated Tropheryma whipplei DNA prevalence in sewer workers.
- reference: PMID:37727483
reference_title: "Diagnosis and treatment of Whipple disease after kidney transplantation: A case report."
supports: PARTIAL
snippet: whipplei) is a Gram-positive actinomycete widely found in soil, sewage, and
explanation: Case report reiterates sewage as an environmental reservoir.
- reference: PMID:40660514
reference_title: "Severe pneumonia caused by Legionella pneumophila associated with Tropheryma whipplei: A case report."
supports: PARTIAL
snippet: Legionella pneumophila (LP) and Tropheryma whipplei (TW) have been identified as pathogens that can coexist in sewage environments.
explanation: Notes coexistence of T. whipplei with other pathogens in sewage.
- reference: PMID:38525769
reference_title: "Whipple Disease Presenting as Isolated Transverse Myelitis with Permanent Neurological Damage in a Patient with Systemic Lupus Erythematosus: A Case Report of a Difficult Diagnosis with a Literature Review."
supports: PARTIAL
snippet: The diagnosis was particularly difficult since lupus and Whipple disease can present similar clinical features and the patient's prolonged contact with sewage was initially not mentioned.
explanation: Highlights sewage exposure preceding Whipple disease presentation.
- name: Soil exposure
description: Soil reported as an environmental reservoir for Tropheryma whipplei.
environment_context:
preferred_term: soil
term:
id: ENVO:00001998
label: soil
evidence:
- reference: PMID:37727483
reference_title: "Diagnosis and treatment of Whipple disease after kidney transplantation: A case report."
supports: SUPPORT
snippet: whipplei) is a Gram-positive actinomycete widely found in soil, sewage, and
explanation: Notes soil as a reservoir where T. whipplei can be encountered.
treatments:
- name: Ceftriaxone induction followed by trimethoprim/sulfamethoxazole
description: Two-week intravenous ceftriaxone induction followed by oral TMP-SMX maintenance to eradicate infection and prevent relapse.
treatment_term:
preferred_term: pharmacotherapy
term:
id: MAXO:0000058
label: pharmacotherapy
therapeutic_agent:
- preferred_term: ceftriaxone
term:
id: CHEBI:29007
label: ceftriaxone
- preferred_term: trimethoprim
term:
id: CHEBI:45924
label: trimethoprim
- preferred_term: sulfamethoxazole
term:
id: CHEBI:9332
label: sulfamethoxazole
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: SUPPORT
snippet: The German treatment recommendations include a two-week intravenous induction therapy with ceftriaxone, which is followed by a three-month oral maintenance therapy with trimethoprim/sulfamethoxazole.
explanation: Details standard ceftriaxone induction and TMP-SMX maintenance regimen.
- name: Doxycycline plus hydroxychloroquine regimen
description: Oral doxycycline and hydroxychloroquine for one year, followed by lifelong doxycycline for relapse prevention.
treatment_term:
preferred_term: pharmacotherapy
term:
id: MAXO:0000058
label: pharmacotherapy
therapeutic_agent:
- preferred_term: doxycycline
term:
id: CHEBI:50845
label: doxycycline
- preferred_term: hydroxychloroquine
term:
id: CHEBI:5801
label: hydroxychloroquine
evidence:
- reference: PMID:26288590
reference_title: "Whipple's Disease."
supports: SUPPORT
snippet: A French group favors a combination of doxycycline and hydroxychloroquine for 1 year, followed by a lifelong administration of doxycycline.
explanation: Review reports alternative long-course doxycycline plus hydroxychloroquine approach.
notes: >
Evidence-backed phenotypes, pathophysiology, differentials, and environmental context
were added using curated abstracts; further curation can expand treatments and additional
organ manifestations.
references:
- reference: DOI:10.1007/s10620-018-5033-4
title: Tropheryma whipplei Infection (Whipple Disease) in the USA
found_in:
- Whipple_Disease-deep-research-falcon.md
findings:
- statement: Tropheryma whipplei Infection (Whipple Disease) in the USA
supporting_text: Tropheryma whipplei Infection (Whipple Disease) in the USA
- reference: DOI:10.1007/s10620-018-5393-9
title: 'Epidemiology of Whipple’s Disease in the USA Between 2012 and 2017: A Population-Based National Study'
found_in:
- Whipple_Disease-deep-research-falcon.md
findings:
- statement: 'Epidemiology of Whipple’s Disease in the USA Between 2012 and 2017: A Population-Based National Study'
supporting_text: 'Epidemiology of Whipple’s Disease in the USA Between 2012 and 2017: A Population-Based National Study'
- reference: DOI:10.1038/s41598-021-91671-9
title: Rheumatological features of Whipple disease
found_in:
- Whipple_Disease-deep-research-falcon.md
findings:
- statement: Whipple disease (WD) is a rare infectious systemic disease.
supporting_text: Whipple disease (WD) is a rare infectious systemic disease.
evidence:
- reference: DOI:10.1038/s41598-021-91671-9
reference_title: Rheumatological features of Whipple disease
supports: SUPPORT
evidence_source: OTHER
snippet: Whipple disease (WD) is a rare infectious systemic disease.
explanation: Deep research cited this publication as relevant literature for Whipple Disease.
- reference: DOI:10.1097/md.0000000000032231
title: 'Whipple’s disease review, prevalence, mortality, and characteristics in the United States: A cross-sectional national inpatient study'
found_in:
- Whipple_Disease-deep-research-falcon.md
findings:
- statement: Whipple’s disease is a rare multiorgan systemic disease caused by Tropheryma whipplei infection that may present with a wide range of signs and symptoms.
supporting_text: Whipple’s disease is a rare multiorgan systemic disease caused by Tropheryma whipplei infection that may present with a wide range of signs and symptoms.
evidence:
- reference: DOI:10.1097/md.0000000000032231
reference_title: 'Whipple’s disease review, prevalence, mortality, and characteristics in the United States: A cross-sectional national inpatient study'
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: Whipple’s disease is a rare multiorgan systemic disease caused by Tropheryma whipplei infection that may present with a wide range of signs and symptoms.
explanation: Deep research cited this publication as relevant literature for Whipple Disease.
- reference: DOI:10.1111/ene.15511
title: The spectrum of central nervous system involvement in Whipple's disease
found_in:
- Whipple_Disease-deep-research-falcon.md
findings:
- statement: The spectrum of central nervous system involvement in Whipple's disease
supporting_text: and purposeTo assess the clinical spectrum of central nervous system (CNS) involvement as well as cerebrospinal fluid (CSF) and neuroimaging findings in patients with Whipple's disease (WD) and to analyze the association of neurological symptoms with CSF and imaging findings.MethodsNeurological involvement was retrospectively analyzed in a series of 36 patients diagnosed with WD at a single center between 1992 and 2019.
evidence:
- reference: DOI:10.1111/ene.15511
reference_title: The spectrum of central nervous system involvement in Whipple's disease
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: and purposeTo assess the clinical spectrum of central nervous system (CNS) involvement as well as cerebrospinal fluid (CSF) and neuroimaging findings in patients with Whipple's disease (WD) and to analyze the association of neurological symptoms with CSF and imaging findings.MethodsNeurological involvement was retrospectively analyzed in a series of 36 patients diagnosed with WD at a single center between 1992 and 2019.
explanation: Deep research cited this publication as relevant literature for Whipple Disease.
- reference: DOI:10.1128/cmr.00033-16
title: Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections
found_in:
- Whipple_Disease-deep-research-falcon.md
findings:
- statement: Whipple's disease is a rare infectious disease that can be fatal if left untreated.
supporting_text: Whipple's disease is a rare infectious disease that can be fatal if left untreated.
evidence:
- reference: DOI:10.1128/cmr.00033-16
reference_title: Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections
supports: SUPPORT
evidence_source: OTHER
snippet: Whipple's disease is a rare infectious disease that can be fatal if left untreated.
explanation: Deep research cited this publication as relevant literature for Whipple Disease.
- reference: DOI:10.1186/s12876-021-01664-1
title: "Whipple's disease: the great masquerader—a high level of suspicion is the key to diagnosis"
found_in:
- Whipple_Disease-deep-research-falcon.md
findings:
- statement: Whipple's disease is a chronic infectious disease that primarily affects the small intestine, but several organs can simultaneously be involved.
supporting_text: Whipple's disease is a chronic infectious disease that primarily affects the small intestine, but several organs can simultaneously be involved.
evidence:
- reference: DOI:10.1186/s12876-021-01664-1
reference_title: "Whipple's disease: the great masquerader—a high level of suspicion is the key to diagnosis"
supports: SUPPORT
evidence_source: OTHER
snippet: Whipple's disease is a chronic infectious disease that primarily affects the small intestine, but several organs can simultaneously be involved.
explanation: Deep research cited this publication as relevant literature for Whipple Disease.
- reference: DOI:10.1186/s12879-023-08276-y
title: Whipple’s disease presenting as weight gain and constipation in a Chinese woman
found_in:
- Whipple_Disease-deep-research-falcon.md
findings:
- statement: Whipple’s disease is a chronic infection due to Tropheryma whipplei, commonly reported in the Caucasian but not in the Chinese population.
supporting_text: Whipple’s disease is a chronic infection due to Tropheryma whipplei, commonly reported in the Caucasian but not in the Chinese population.
evidence:
- reference: DOI:10.1186/s12879-023-08276-y
reference_title: Whipple’s disease presenting as weight gain and constipation in a Chinese woman
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: Whipple’s disease is a chronic infection due to Tropheryma whipplei, commonly reported in the Caucasian but not in the Chinese population.
explanation: Deep research cited this publication as relevant literature for Whipple Disease.
- reference: DOI:10.2147/idr.s488740
title: 'Short-Term Amoxicillin Clavulanate in the Treatment of Pulmonary Abscess Caused by Tropheryma whipplei Infection Diagnosed by Targeted Next-Generation Sequencing: A Case Report and Literature Review'
found_in:
- Whipple_Disease-deep-research-falcon.md
findings:
- statement: 'Short-Term Amoxicillin Clavulanate in the Treatment of Pulmonary Abscess Caused by Tropheryma whipplei Infection Diagnosed by Targeted Next-Generation Sequencing: A Case Report and Literature Review'
supporting_text: 'Short-Term Amoxicillin Clavulanate in the Treatment of Pulmonary Abscess Caused by Tropheryma whipplei Infection Diagnosed by Targeted Next-Generation Sequencing: A Case Report and Literature Review'
- reference: DOI:10.2217/fmb-2019-0315
title: 'Long-Term Morbidity and Mortality in Whipple’s Disease: A Single-Center Experience Over 20 Years'
found_in:
- Whipple_Disease-deep-research-falcon.md
findings:
- statement: 'Long-Term Morbidity and Mortality in Whipple’s Disease: A Single-Center Experience Over 20 Years'
supporting_text: 'Long-Term Morbidity and Mortality in Whipple’s Disease: A Single-Center Experience Over 20 Years'
- reference: DOI:10.3389/fimmu.2023.1265414
title: 'Current knowledge of the immune reconstitution inflammatory syndrome in Whipple disease: a review'
found_in:
- Whipple_Disease-deep-research-falcon.md
findings:
- statement: Immune reconstitution inflammatory syndrome (IRIS) is characterized by exaggerated and dysregulated inflammatory responses that occur as a result of reconstitution of adaptive or innate immunity.
supporting_text: Immune reconstitution inflammatory syndrome (IRIS) is characterized by exaggerated and dysregulated inflammatory responses that occur as a result of reconstitution of adaptive or innate immunity.
evidence:
- reference: DOI:10.3389/fimmu.2023.1265414
reference_title: 'Current knowledge of the immune reconstitution inflammatory syndrome in Whipple disease: a review'
supports: SUPPORT
evidence_source: OTHER
snippet: Immune reconstitution inflammatory syndrome (IRIS) is characterized by exaggerated and dysregulated inflammatory responses that occur as a result of reconstitution of adaptive or innate immunity.
explanation: Deep research cited this publication as relevant literature for Whipple Disease.
- reference: DOI:10.7759/cureus.34029
title: Why Is Whipple's Disease Still a Challenging Diagnosis? A Case Report and Brief Review of Literature
found_in:
- Whipple_Disease-deep-research-falcon.md
findings:
- statement: Why Is Whipple's Disease Still a Challenging Diagnosis? A Case Report and Brief Review of Literature
supporting_text: Why Is Whipple's Disease Still a Challenging Diagnosis? A Case Report and Brief Review of Literature